# Thoracoscopic Ablation for Lone Atrial Fibrillation

> **NCT05708027** · PHASE3 · UNKNOWN · sponsor: **Federal Research Clinical Center of Federal Medical & Biological Agency, Russia** · enrollment: 232 (actual)

## Conditions studied

- Atrial Fibrillation
- Heart Diseases

## Interventions

- **PROCEDURE:** Thoracoscopic surgical ablation

## Key facts

- **NCT ID:** NCT05708027
- **Lead sponsor:** Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-06
- **Primary completion:** 2022-08-31
- **Final completion:** 2023-09-30
- **Target enrollment:** 232 (ACTUAL)
- **Last updated:** 2023-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05708027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05708027, "Thoracoscopic Ablation for Lone Atrial Fibrillation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05708027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*